Arca
Skip to content
Tools
Tools

Citrated: K, KH, RTH, FFH

System, Multipurpose For In Vitro Coagulation Studies. 510(k) K232018, from Haemonetics Corporation (Boston, MA). Product code JPA, class 2.

As of Nov 18, 2026, K232018 is an FDA 510(k) held by Haemonetics Corporation, substantially equivalent on Mar 29, 2024 after 266 days, with no recalls tied to it in FDA's recall database.

  • Review time: 266 days
  • Recalls: 0

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The TEG 6s Hemostasis System consists of the TEG 6s Hemostasis Analyzer and the Citrated: K, KH, RTH, FFH assay cartridge. The TEG 6s Hemostasis System is intended for in vitro diagnostic use with adult patients where an evaluation of their blood hemostasis properties is desired.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other JPA clearances

The newest 510(k)s for the same product code; their median review was 158 days; see every JPA device

Record

Type
Traditional
Received
Jul 7, 2023
Review panel
Hematology
Regulation
21 CFR 864.5425

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.